These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27693855)

  • 21. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
    Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
    Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of synthesis of cytochrome c oxidase 2 and TP53-induced glycolysis and apoptosis regulator can predict poor prognosis in human lung adenocarcinoma.
    Liu J; Lu F; Gong Y; Zhao C; Pan Q; Ballantyne S; Zhao X; Tian S; Chen H
    Hum Pathol; 2018 Jul; 77():54-62. PubMed ID: 29634976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
    Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
    Int J Cancer; 2005 Feb; 113(5):730-7. PubMed ID: 15499630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Chartomatsidou E; Kotta K; Agathangelidis A; Giassafaki L; Karamanli T; Bele P; Moysiadis T; Baliakas P; Sutton LA; Stavroyianni N; Anagnostopoulos A; Makris AM; Ghia P; Rosenquist R; Stamatopoulos K
    Oncotarget; 2016 Jun; 7(24):35946-35959. PubMed ID: 27191993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of puma mRNA levels by real-time quantitative RT-PCR in chronic lymphocytic leukemia and its clinical significance].
    Zhu HJ; Xu W; Cao X; Fang C; Zhu DX; Dong HJ; Wang DM; Qiao C; Miao KR; Liu P; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):843-8. PubMed ID: 20723285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins.
    Faria JR; Yamamoto M; Faria RM; Kerbauy J; Oliveira JS
    Braz J Med Biol Res; 2006 Mar; 39(3):327-33. PubMed ID: 16501812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress.
    Kimata M; Matoba S; Iwai-Kanai E; Nakamura H; Hoshino A; Nakaoka M; Katamura M; Okawa Y; Mita Y; Okigaki M; Ikeda K; Tatsumi T; Matsubara H
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1908-16. PubMed ID: 20935145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells.
    Vangapandu HV; Ayres ML; Bristow CA; Wierda WG; Keating MJ; Balakrishnan K; Stellrecht CM; Gandhi V
    Neoplasia; 2017 Oct; 19(10):762-771. PubMed ID: 28863345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis.
    Bacalini MG; Tavolaro S; Peragine N; Marinelli M; Santangelo S; Del Giudice I; Mauro FR; Di Maio V; Ricciardi MR; Caiafa P; Chiaretti S; Foà R; Guarini A; Reale A
    Exp Hematol; 2012 Mar; 40(3):197-206.e1. PubMed ID: 22120020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of LPL gene expression in patients with chronic lymphocytic leukemia.
    Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
    Exp Oncol; 2019 Mar; 41(1):39-45. PubMed ID: 30932419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of VH genes mutation status for prognosis of CLL patients.
    Bilous N; Abramenko I; Kryachok I; Bazyka D; Chumak A; Bebeshko V
    Exp Oncol; 2005 Dec; 27(4):325-9. PubMed ID: 16404355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinctive interrelation of p53 with SCO2, COX, and TIGAR in human gastric cancer.
    Kim SH; Choi SI; Won KY; Lim SJ
    Pathol Res Pract; 2016 Oct; 212(10):904-910. PubMed ID: 27499152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indole-3-Carbinol Synergizes with and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of p53 Activity and Treatment Resistances.
    Perez-Chacon G; Martinez-Laperche C; Rebolleda N; Somovilla-Crespo B; Muñoz-Calleja C; Buño I; Zapata JM
    Clin Cancer Res; 2016 Jan; 22(1):134-45. PubMed ID: 26324744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
    Hegde GV; Peterson KJ; Emanuel K; Mittal AK; Joshi AD; Dickinson JD; Kollessery GJ; Bociek RG; Bierman P; Vose JM; Weisenburger DD; Joshi SS
    Mol Cancer Res; 2008 Dec; 6(12):1928-36. PubMed ID: 19074837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia.
    Kontos CK; Papageorgiou SG; Diamantopoulos MA; Scorilas A; Bazani E; Vasilatou D; Gkontopoulos K; Glezou E; Stavroulaki G; Dimitriadis G; Pappa V
    Leuk Res; 2017 Feb; 53():65-73. PubMed ID: 28038356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells.
    Dai Q; Yin Y; Liu W; Wei L; Zhou Y; Li Z; You Q; Lu N; Guo Q
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1468-78. PubMed ID: 23612020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
    Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia.
    Merkel O; Wacht N; Sifft E; Melchardt T; Hamacher F; Kocher T; Denk U; Hofbauer JP; Egle A; Scheideler M; Schlederer M; Steurer M; Kenner L; Greil R
    Leukemia; 2012 Dec; 26(12):2508-16. PubMed ID: 22743622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
    Rigolin GM; Formigaro L; Cavallari M; Quaglia FM; Lista E; Urso A; Guardalben E; Martinelli S; Saccenti E; Bassi C; Lupini L; Bardi MA; Volta E; Tammiso E; Melandri A; Negrini M; Cavazzini F; Cuneo A
    Oncotarget; 2017 Apr; 8(17):28008-28020. PubMed ID: 28427204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.